Oventus Medical Ltd

ASX:OVN ISIN:AU000000OVN3

Oventus Medical Ltd (ASX:OVN) is a Brisbane based medical device company that is commercialising a suite of oral appliances for the treatment of sleep apnoea and snoring. Unlike other oral appliances, the Oventus devices have a unique and patented airway within the device that delivers air to the back of the mouth bypassing multiple obstructions from the nose, soft palate and tongue. They are particularly designed for the many people that have nasal obstructions and consequently tend to mainly breathe through their mouth. While it may seem counterintuitive, the device actually prevents oral breathing. The O2Vent is designed to allow nasal breathing when the nose is unobstructed, but when obstruction is present, breathing is supplemented via the airways in the appliance.

A clinical study completed earlier this year showed the company's first generation product the O2Vent Mono(TM) is successful in treating OSA and that snoring was either eliminated or significantly reduced to 100 per cent of patients. The positive results included those people who had nasal obstructions and mainly breathed through their mouths, including when they were asleep. It also improves oxygen levels for patients.

According to a report published by the Sleep Health Foundation Australia, an estimated 1.5 million Australians suffer with sleep disorders and more than half of these suffer with obstructive sleep apnoea.

Continuous positive airway pressure (CPAP) is the most definitive medical therapy for obstructive sleep apnoea, OSA, however many patients have difficulty tolerating CPAP. Oral appliances have emerged as an alternative to CPAP for obstructive sleep apnoea treatment.

       

News

Oventus Medical Ltd (ASX:OVN) Maskless C-PAP One Step Closer

🕔6/2/2017 11:04:23 AM 2167

Oventus Medical Ltd (ASX:OVN) are pleased to announce that C-PAP (Continuous Positive Airway Pressure) without a mask is one step closer signalling the first major change in sleep medicine in decades. The first patient has been recruited in the next stage of a trial combining an oral appliance and C-PAP.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Signs Manufacturing Agreement with Modern Dental

🕔5/30/2017 9:04:46 AM 2000

Oventus Medical Ltd (ASX:OVN) is pleased to announce it has entered into a manufacturing agreement with Hong Kong based Modern Dental Group. Modern Dental have extensive expertise in the manufacture of dental appliances and hold the required quality management certifications for medical device manufacture.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Treatment Addresses Snorers at Higher Risk of Traffic Accidents

🕔5/29/2017 12:25:26 PM 1752

The daily commute from Geelong to Melbourne just got a little more perilous with a new study warning one fifth of Australian adults have fallen asleep while driving. Research from the Sleep Health Foundation also shows nearly a third of Australians drive while drowsy at least once a month. They're figures Geelong dentist Dr Joseph Juric said are only scratching the surface.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Advances in Combatting Sleep Apnoea

🕔5/11/2017 2:01:36 PM 2410

Treatment for sleep apnoea usually involves either a mask or a mouthguard. A new Australian invention combines the best elements of both. Brisbane dentist Chris Hart spent years struggling to sleep. He snored constantly. He often woke up during the night because he had stopped breathing because of a n obstruction in his nose and throat.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Innovators in Sleep Apnoea Treatment

🕔5/11/2017 10:30:12 AM 1718

Oventus Medical Ltd (ASX:OVN) is pleased to provide the Company's latest Investor Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) FDA Submission Lodged for O2Vent W

🕔5/5/2017 8:33:39 AM 1849

Australian medical device company Oventus Medical Ltd. (ASX:OVN), has lodged an FDA 510k submission for its O2Vent W device - an oral appliance intended to reduce or alleviate snoring, mild to moderate obstructive sleep apnoea and severe sleep apnoea when the patient is intolerant to Continuous Positive Airway Pressure Devices.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Clinical Evidence Update

🕔5/3/2017 1:28:58 PM 2797

Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant progress has been made regarding the clinical validation of the Oventus O2Vent oral appliances and, in particular, validation of the benefit of the Oventus proprietary airway.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Clinical Update on Advancing PAP Connection of O2Vent

🕔5/1/2017 12:01:11 PM 1535

Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant clinical progress made with the Oventus O2Vent oral appliance with a Positive Airway connection.

Read Full Article

Oventus Medical Ltd (ASX:OVN) - is This What the Future of Treating Sleep Apnea Looks Like?

🕔4/10/2017 9:43:44 AM 3319

Oventus Medical Ltd (ASX:OVN) will unveil latest advancements in the field, which are changing the way the disease is treated, in San Francisco next week (April 20th). Dr Chris Hart will join more than 30 international speakers at 3DHEALS2017 - the first collaborative conference in the U.S. aiming to create a global healthcare community focusing on 3D printing and related technologies.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Update: Achieves Significant Milestones in Last Quarter and Expands Commercialisation of O2Vent T

🕔4/4/2017 3:45:08 PM 2750

Oventus Medical Ltd (ASX:OVN) are pleased to provide the Company's latest Investor Update. Oventus have achieved a number of significant milestones in the last quarter, expanding the commercialisation efforts of our O2Vent(TM) T device in numerous geographical regions and strengthening our sales and operational systems.

Read Full Article
###

7,808 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 129) (Last 30 Days: 492) (Since Published: 7808) 

Markets ASX:OVN

Company Data

    Headquarters
  • 1 Swann Road
    Indooroopilly
    PO Box 190, Indooroopilly
    4068 QLD Australia
  • Telephone
  • 1300 533 159 
  • Principal Sector
  • Chemical Equipment & Manufacturing 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.oventus.com.au

Company Reports

Presentations

Quarterly Report

Social Media